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Background: As one of the causative agents of viral hepatitis, hepatitis E virus (HEV) has gained public health
attention globally. HEV epidemics occur in developing countries, associated with faecal contamination of water
and poor sanitation. In industrialised nations, HEV infections are associated with travel to countries endemic for
HEV, however, autochthonous infections, mainly through zoonotic transmission, are increasingly being reported.
HEV can also be transmitted by blood transfusion. Nepal has experienced a number of HEV outbreaks, and recent
earthquakes resulted in predictions raising the risk of an HEV outbreak to very high. This study aimed to measure
HEV exposure in Nepalese blood donors after large earthquakes.
Methods: Samples (n = 1,845) were collected from blood donors from Kathmandu, Chitwan, Bhaktapur and Kavre.
Demographic details, including age and sex along with possible risk factors associated with HEV exposure were
collected via a study-specific questionnaire. Samples were tested for HEV IgM, IgG and antigen. The proportion of
donors positive for HEV IgM or IgG was calculated overall, and for each of the variables studied. Chi square and
regression analyses were performed to identify factors associated with HEV exposure.
Results: Of the donors residing in earthquake affected regions (Kathmandu, Bhaktapur and Kavre), 3.2% (54/1,686;
95% CI 2.7–4.0%) were HEV IgM positive and two donors were positive for HEV antigen. Overall, 41.9% (773/1,845;
95% CI 39.7–44.2%) of donors were HEV IgG positive, with regional variation observed. Higher HEV IgG and IgM
prevalence was observed in donors who reported eating pork, likely an indicator of zoonotic transmission.
Previous exposure to HEV in Nepalese blood donors is relatively high.
Conclusion: Detection of recent markers of HEV infection in healthy donors suggests recent asymptomatic HEV
infection and therefore transfusion-transmission in vulnerable patients is a risk in Nepal. Surprisingly, this study
did not provide evidence of a large HEV outbreak following the devastating earthquakes in 2015.
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Hepatitis E virus (HEV) has gained public health attention
as one of the causative agents of viral hepatitis. The four
genotypes of this non-enveloped RNA virus differ in mode
of transmission and geographical occurrence [1, 2]. In
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faecal-oral route [1, 3]. In developed countries, HEV has
traditionally been associated with travel to countries
endemic for HEV [4, 5], however, locally acquired HEV
infections, associated with zoonotic transmission, are in-
creasingly reported in such countries [5–8].
In Nepal, regular HEV outbreaks have occurred during
the previous 4 decades, with reported outbreaks in 1973,
1981–1982, 1987, 1995 and 2014 [9–11]. During these
outbreaks, a maternal mortality rate of 21–25% was re-
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in 1999–2000 was estimated to be 38% among the gen-
eral population of Nepal [9]. Kathmandu was designated
hyper-endemic for HEV, with rural areas non-endemic
[9]. A recent study has demonstrated HEV IgG preva-
lence of 47% among patients visiting a hospital in
Kathmandu [12]. HEV infections have also been re-
ported in travellers to Nepal [13–15]. Poor infrastructure
development in terms of water supply and sewerage sys-
tems can facilitate the contamination of drinking water
[16], especially during the summer monsoon season
[17]. Epidemics have been associated with faecal con-
tamination of water, and molecular characterization has
shown genotype 1 as a cause of acute HEV infection
[18]. HEV antibodies and RNA have been detected in
farm swine from Kathmandu [19], indicating the possi-
bility of zoonotic transmission in addition to the usual
faeco-oral route.
The recent devastating earthquakes that occurred on
25th April and 12th May 2015 in Nepal raised concerns
that the risk of an imminent HEV outbreak was very
high, with HEV possibly causing up to 510 deaths in
pregnant women [20]. During these earthquakes and
their aftermath, 8,891 people lost their lives [21], with
many left homeless having to share common shelter
under tents for months. Under such overcrowded living
conditions poor sanitation and hygiene were likely and
individuals no doubt had limited access to safe drinking
water, contributing to increased potential for infectious
disease outbreaks [20, 22]. The burden of HEV at this
time was also expected to be high due to the ap-
proaching summer monsoon season and limited access
to health facilities [20, 23]. We therefore sought to esti-
mate the rate of previous and recent HEV infection in
Nepalese blood donors in the months following the large
earthquakes. This study aimed to provide surveillance
data about HEV in Nepal, determine the possible impact
of the recent earthquakes through serological evidence
of recent HEV exposure, and analyse variables as pos-
sible risk factors for exposure to HEV.
Methods
Sample population
A total of 1,845 blood donors eligible to donate blood
as per the criteria of the Central Blood Transfusion
Service (CBTS), Nepal Red Cross Society (NRCS) were
included in this study. A cross section of samples were
collected at blood transfusion services in Kathmandu
(n = 1,435), Chitwan (n = 159), Bhaktapur (n = 135), and
Kavre (n = 116), during the months June-September,
2015. The required sample size for Kathmandu was es-
timated, using standard methods [24], to be 1,448,
based on the assumption of 38% HEV IgG prevalence
[9], 95% confidence interval, and an absolute precisionof 2.5%. Sample numbers from the other districts were
based on accessibility to the donor population.
Sample collection
Blood donor samples were collected in BD Vacutainer®
PPT Plasma Preparation Tubes (Becton, Dickson and
Company (BD) Biosciences, San Diego, USA). Samples
were centrifuged at 2,500 rpm for 5 min before storage
at −20 °C until testing.
Variables obtained through additional questionnaire
In order to identify possible risk factors associated with
HEV exposure, the following variables were included in
the additional questionnaire:
1. Donor status: Donors who had previously donated
were categorised as repeat donors and those who
were donating for the first time as new donors.
2. History of jaundice: Jaundice was defined as any
known feature of jaundice including yellow
discolouration of skin and hepatitis, whether or not
a donor required medical support. Family member
jaundice referred to when any family member of a
donor had jaundice, as defined above.
3. Source of drinking water: Donors were asked about
their drinking water source, whether it be from a
community tap, municipality tap, or underground.
Community tap refers to a common tap in the
community with a reservoir tank in that local area.
Municipality tap is treated/purified and is usually
supplied to the home by the local government
authority. An underground source refers to any
ground water source including hand-pumps and
wells. Donors responding to two or more options
were categorised as relying on multiple sources.
Those reporting sources other than those
mentioned above including bottled water were
categorised as ‘other’.
4. Drinking water treatment method: Donors were
asked how they treated water for drinking purposes,
which included: boiling (boiling water prior to
drinking); filtering (filtration of water); chemical
treatment (use of water purifier chemicals); or, no
treatment (drinking directly from source). Donors
with multiple options selected were categorised as
multiple methods.
5. Vegetarianism: Donors who ate meat were
categorised as non-vegetarian, while others were
categorised as vegetarian.
6. Pork consumption: Non-vegetarians who ate pork
were categorised as pork consumers and others as
pork non-consumers.
7. International travel: Donors who had travelled to
other countries were categorised as international
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non-travellers.
Sample testing
All samples were de-linked prior to testing. Plasma sam-
ples were tested individually for HEV IgM (Wantai
HEV-IgM ELISA, Beijing Wantai Biological Pharmacy
Enterprise Co., Ltd, Beijing, China), as per the manufac-
turer’s instructions. Any samples testing positive were
re-tested in duplicate. Samples that were reactive two or
three times were reported as HEV IgM positive. All sam-
ples were also tested for HEV-IgG (Wantai HEV IgG
ELISA, Beijing Wantai Biological Pharmacy Enterprise
Co., Ltd) and HEV antigen (Wantai HEV-AgPlus ELISA,
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd)
as per the manufacturer’s instructions, using the same
testing algorithm as mentioned above for HEV IgM.
Statistical analysis
Donor data obtained from the questionnaire were en-
tered in to a Microsoft Excel 2010 (Redmond, WA,
USA) database. Proportions of donors HEV IgG, IgM or
antigen positive were calculated overall and for each of
the study variables, and 95% confidence intervals esti-
mated. IBM SPSS Statistics 23 (IBM Centre, NSW,
Australia) was used to analyse for statistical inference
(chi-square, odds ratio) and to determine association
with variables. Some donors did not answer some of the
questions on the questionnaire, resulting in missing data
for some variables. In these instances, the missing data
were subjected to multiple imputations prior to regres-
sion analyses. Thus, in the absence of data from donors
not responding to the study variables, potential bias in
the inference could not be excluded. In addition, donors’
responses to the questions were based on recollection,
introducing the risk of possible recall bias.
Results
Of the 1,845 samples tested, 55 (3.0%, 95% CI 2.2–3.8%)
were positive for HEV IgM. The proportion of donors
with both HEV IgM and IgG was 2.7%. HEV IgM preva-
lence was associated with a donor reporting having a his-
tory of jaundice or reporting pork consumption (p < 0.05)
(multivariate analysis) (Table 1). No associations were
observed for the other factors investigated (Table 1).
Of the donors residing in earthquake affected regions
(Kathmandu, Bhaktapur and Kavre), 3.2% (95% CI
2.7–4.0%) of donors were HEV IgM positive, and two
donors were positive for HEV antigen. These HEV
antigen positive individuals were also HEV IgG posi-
tive (Table 2), but negative for HEV IgM. Both HEV
antigen positive donors were from Kathmandu and
36 years of age.HEV IgG was detected in 773 of the 1,845 samples
tested (41.9%, 95% CI 39.7–44.2%). The prevalence was
significantly higher (p < 0.05) in Bhaktapur, Kavre and
Kathmandu than the Chitwan district (Table 3). HEV
IgG prevalence increased with increasing age and was
highest (85.7%) in individuals above 55 years (p < 0.05).
HEV IgG prevalence was also higher in repeat blood
donors, those with a history of jaundice and those
reporting pork consumption (p < 0.05) (multivariate
analysis) (Table 3). Individuals who relied on drinking
underground water were associated with having a lower
HEV IgG prevalence (p < 0.05) (multivariate analysis)
(Table 3).
Discussion
HEV outbreaks occur sporadically in developing coun-
tries due to faecal contamination of water and poor
sanitation [25]. Given a relatively high mortality rate
(0.2–4%), which is particularly high in pregnant women
(10–25%) [17], HEV is a topic of public health concern
in developing countries. Recent devastating earthquakes
in Nepal could have facilitated an outbreak of HEV. In
this study, we measured previous and current HEV in-
fection in Nepalese blood donors after recent major
earthquakes to provide surveillance data on HEV in
Nepal and to determine possible risk factors for HEV
exposure.
This study was conducted during the months June-
September, 2015, after the devastating earthquakes and
the monsoon season period, when waterborne outbreaks
of HEV were likely to occur [20, 26]. Bhaktapur, Kavre
and Kathmandu were among the earthquake-affected
districts. In these regions, we report that 3.2% (54/1,686)
of the healthy population demonstrated recent HEV ex-
posure (through detection of HEV IgM) and we detected
two donors with HEV antigen. The rate of HEV IgM
prevalence was lower in the non-earthquake affected
region, Chitwan, where a similar pattern was observed
for HEV IgG. This suggests less HEV transmission in
the Chitwan district. During an epidemic in Biratna-
gar, Nepal, 2014, HEV IgM prevalence was as high as
94–100% in acute hepatitis patients [11]. In our study,
subjects were blood donors, considered healthy and there-
fore would not capture the symptomatic group of the
population. HEV IgM and antigen detection are likely to
represent asymptomatic infections in blood donors. Since
symptomatic HEV cases are unlikely to be included, study-
ing blood donors may result in an inability to detect the
full magnitude of an outbreak. Selecting well donors may
additionally result in selection bias of those with pre-
existing immunity in hyperendemic areas. However, given
that 50% of HEV cases in developing countries are asymp-
tomatic [3], we assume we have identified about half of
the cases during this time.
Table 1 HEV IgM seroprevalence in Nepalese blood donors









Female 306 4 1.3 (0.0–2.6) a
Male 1,539 51 3.3 (2.4–4.2) 2.6 (0.9–7.2) >0.05
Age >0.05
<25 years 735 18 2.5 (1.3–3.6) a
25–34 years 682 22 3.2 (1.9–4.6) 1.3 (0.7–2.5) >0.05
35–44 years 315 10 3.2 (1.2–5.1) 1.3 (0.6–2.9) >0.05
45–54 years 99 5 5.1 (0.7–9.4) 2.1 (0.8–5.8) >0.05
55–64 years 14 0 0 0 >0.05
District >0.05
Bhaktapur 135 6 4.4 (1.0–7.9) 7.4 (0.9–61.8) >0.05
Kavre 116 3 2.6 (0–5.47) 4.2 (0.4–40.9) >0.05
Kathmandu 1,435 45 3.1 (2.2–4.0) 5.12 (0.7–37.4) >0.05
Chitwan 159 1 0.6 (0–1.9) a
Donor status
Repeat 1,265 40 3.2 (2.2–4.1) 1.2 (0.7–2.2) >0.05
First time 580 15 2.6 (1.3–3.9) a
History of Jaundice
Yes 212 13 6.1 (2.9–9.4) 2.6 (1.4–4.9) <0.05 2.5 (1.3–4.7) <0.05
No 1,633 42 2.5 (1.8–3.3) a
Family history of jaundice
Yes 226 8 3.5 (1.1–6.0) 1.3 (0.6–2.7) >0.05
No 1,619 47 2.9 (2.1–3.7) a
Drinking Water Source >0.05
Community tap 274 10 3.7 (1.4–5.9) 1.01 (0.3–3.04) >0.05
Municipality 940 20 2.1 (1.2–3.1) 0.57 (0.2–1.4) >0.05
Others 296 14 4.7 (2.3–7.2) 1.05 (0.2–5.29) >0.05
Multiple sources 60 2 3.3 (0–7.9) 1.2 (0.5–3.1) >0.05
Underground 250 9 3.6 (1.2–5.9) a
Drinking water treatment >0.05
Boiling 315 13 4.1 (1.9–6.3) a
Filtering 1,030 30 2.9 (1.9–3.9) 0.7 (0.4–1.5) >0.05
Chemical treatment 50 1 2.0 (0–5.9) 0.5 (0.1–3.9) >0.05
Multiple methods 202 4 2.0 (0.1–3.9) 0.5 (0.2–1.7) >0.05
No treatment 248 7 2.8 (0.8–4.9) 0.7 (0.3–1.8) >0.05
Vegetarianism
Yes 1,663 48 2.9 (2.1–3.7) a
No 182 7 3.9 (1.1–6.6) 1.4 (0.6–3.2) >0.05
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Table 1 HEV IgM seroprevalence in Nepalese blood donors (Continued)
Pork consumption
Yes 700 29 4.1 (2.7–5.6) 1.9 (1.1–3.3) <0.05 1.8 (1.0–3.2) <0.05
No 1,145 26 2.3 (1.4–3.1) a
International travel
Yes 565 15 2.7 (1.3–4.0) a
No 1,280 40 3.1 (2.2–4.1) 1.2 (0.6–2.1) >0.05
aReference group
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tected in 2 donors from Kathmandu. Both of these do-
nors were positive for HEV IgG, but negative for HEV
IgM. This indicates HEV antigen is likely to persist for a
short period, and is undetectable by the time of appear-
ance of HEV IgM. A study has shown that 19% (3/16) of
HEV antigen positive samples were HEV IgM negative
[27]. Concurrent detection of HEV antigen and IgG in
both our donors could indicate re-infection, however,
non-specificity of the antigen assay cannot be ruled out.
In the absence of HEV RNA testing, the infectious state
of antibody and/or antigen positive donors could not be
determined.
In the absence of complete population data during epi-
demic and inter-epidemic periods of HEV circulation,
there is no definitive IgM positivity proportion that can
be used to define a recent outbreak. The majority of
serological studies in epidemics are done in acute cases,
and not relevant to background population seropreva-
lence. However, population serosurveys during known
large outbreaks indicate a higher prevalence of IgM
positivity than detected in our study. In Sudan in 2012
a serosurvey performed before a large outbreak peak in
refugee camps demonstrated an IgM positivity rate of
21.7% [28]. Similarly, in a serosurvey of children agedTable 2 HEV antigen positive blood donors
Variable Sample 1059 Sample 1303
Collection Date 12/06/2015 13/06/2015
Collection District Kathmandu Kathmandu
Age 36 36
Sex Male Female
History of Jaundice Yes No
Family history of jaundice No No
Drinking water source Municipality Municipality
Vegetarianism No No
Pork Consumption No No response
International travel No No
HEV IgG Positive Positive
HEV IgM Negative Negative
HEV antigen Positive Positive0–15 during an Ugandan outbreak, IgM positivity was
37.3% [29]. In endemic areas, asymptomatic positivity
in blood donors varies from 0.5 to 5% [30–34]. Our
finding of 3.2% IgM positivity in blood donors from
earthquake-affected regions is consistent with ongoing
endemic transmission. Therefore, we did not find
strong evidence of a large post-earthquake HEV out-
break. Persistence of HEV IgG offers protection from
subsequent infection; it has been observed that HEV
outbreaks occur every few years in India, perhaps cor-
responding to when herd immunity drops below a
threshold [35]. Thus high antibody levels present in the
Nepalese population due to previous outbreaks could
have provided immunity against re-infection of the ex-
posed population.
HEV outbreaks in Nepal are either focal (where a large
number of cases occur over days to weeks in a well-
defined small population) or epidemic [9]. This study
did not have the power to detect a focal outbreak. The
failure of this study to provide evidence of a large HEV
outbreak in the months directly following the earth-
quakes reflects either inability of the study to detect the
outbreak, or the absence of a HEV outbreak. It has been
estimated that 390,000 individuals left the Kathmandu
region immediately following the earthquakes, with
movements into the area significantly below normal
[36]. These population flows may have decreased the
HEV population susceptibility. If migrant populations
with lower HEV immunity were disproportionately re-
moved from the at risk population this would decrease
the likelihood of an outbreak. The impact of earthquake
relief support to public health threats such as provision
of clean water and increased awareness of the risk may
have also decreased the likelihood of an outbreak. Alter-
natively, given the lack of baseline HEV IgM positivity in
Nepalese blood donors, it may be that 3.2% exposure
represents a small outbreak. This argument is strength-
ened by the prolonged epidemic pattern that typically
occurs in Kathmandu and the transient nature of IgM
positivity [37]. However, there are no recent published
reports on HEV clinical cases that would indicate an
outbreak in the general population post-earthquake.
Since HEV in developing countries is commonly asso-
ciated with drinking contaminated water, there is less
Table 3 HEV IgG seroprevalence in Nepalese blood donors









Female 306 109 35.6 (30.3–41.0) a a
Male 1,539 664 43.1 (40.7–45.6) 1.4 (1.1–1.8) <0.05 1.3 (1.0–1.7) >0.05
Age <0.05 <0.05
<25 years 735 155 21.1 (18.1–24.0) a a
25–34 years 682 330 48.4 (44.6–52.1) 3.5 (2.8–4.4) <0.05 3.5 (2.7–4.5) <0.05
35–44 years 315 203 64.4 (59.2–69.7) 6.8 (5.1–9.1) <0.05 7.6 (5.5–10.5) <0.05
45–54 years 99 73 73.7 (65.1–82.4) 10.5 (6.5–17.0) <0.05 10.9 (6.5–18.3) <0.05
55–64 years 14 12 85.7 (67.4–44.2) 22.5 (5.0–101.4) <0.05 24.6 (4.9–124.3) <0.05
District <0.05 <0.05
Bhaktapur 135 74 54.8 (46.4–63.2) 10.8 (5.9–20.1) <0.05 13.5 (7.0–26.1) <0.05
Kavre 116 52 44.8 (35.8–53.9) 7.3 (3.9–13.7) <0.05 7.0 (3.6–13.8) <0.05
Kathmandu 1,435 631 44.0 (41.4–46.5) 7.0 (4.1–11.9) <0.05 8.0 (4.6–14.0) <0.05
Chitwan 159 16 10.1 (5.4–14.7) a a
Donor status
Repeat 1,264 606 47.9 (45.2–50.7) 2.3 (1.8–2.8) <0.05 1.4 (1.1–1.7) <0.05
First time 581 167 28.7 (25.1–32.4) a a
History of Jaundice
Yes 213 119 55.9 (49.2–62.5) 1.9 (1.4–2.6) <0.05 2.0 (1.4–2.7) <0.05
No 1,632 654 40.1 (37.7–42.5) a a
Family history of jaundice
Yes 227 114 50.2 (43.7–56.7) 1.47 (1.10–1.97) <0.05 1.2 (0.9–1.8) >0.05
No 1,618 659 40.7 (38.3–43.1) a a
Drinking Water Source <0.05 <0.05
Community tap 273 103 37.7 (32.0–43.5) 1.2 (0.8–1.7) >0.05 1.4 (1.0–1.9) <0.05
Municipality 940 423 45.00 (41.8–48.2) 1.6 (1.2–2.2) <0.05 0.9 (0.5–1.8) >0.05
Others 309 135 43.7 (38.2–49.2) 1.3 (0.7–2.3) >0.05 1.2 (0.8–1.7) >0.05
Multiple sources 63 25 39.7 (27.6–51.8) 1.5 (1.1–2.2) <0.05 0.8 (0.6–1.2) >0.05
Underground 260 87 33.5 (27.7–39.2) a a
Drinking water treatment >0.05
Boiling 315 117 37.1 (31.8–42.5) a
Filtering 1,030 448 43.5 (40.5–46.5) 1.3 (1.0–1.7) <0.05
Chemical treatment 49 18 36.7 (23.2–50.2) 1.0 (0.5–1.9) >0.05
Multiple methods 203 91 44.8 (38.0–51.7) 1.4 (1.0–2.0) >0.05
No treatment 248 99 39.9 (33.8–46.0) 1.1 (0.8–1.6) >0.05
Vegetarianism
Yes 1,662 701 42.2 (39.8–44.6) 1.1 (0.8–1.6) >0.05
No 183 72 39.3 (32.3–46.4) a
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Table 3 HEV IgG seroprevalence in Nepalese blood donors (Continued)
Pork consumption
Yes 701 323 46.1 (42.4–49.8) 1.3 (1.1–1.6) <0.05 1.3 (1.0–1.6) <0.05
No 1,144 450 39.3 (36.5–42.2) a a
International travel
Yes 565 280 49.6 (45.4–53.7) 1.6 (1.3–1.9) <0.05 0.9 (0.7–1.2) >0.05
No 1,280 493 38.5 (35.9–41.2) a a
aReference group
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transfusion safety. A retrospective study in India has
shown a higher prevalence of HEV infection markers
among blood transfusion recipients compared to control
groups [38]. HEV is a possible risk to blood supply safety
in developed countries [39–41]. For developing coun-
tries, however, the main concerns are other modes of
transmission, which are the major contributor to the
burden of disease. However, HEV can cause chronic in-
fection in immunocompromised individuals [17, 42], and
contributes to a higher mortality rate in women during
third trimester of pregnancy [3]. Hence, a safe blood
supply for these high-risk vulnerable patients should also
be of concern in developing countries.
Higher HEV IgG and IgM prevalence was observed in
donors who reported eating pork, which is likely an indi-
cator of zoonotic transmission [8]. HEV RNA of un-
known genotype and antibodies have been detected in
domestic swine in Kathmandu [19]. This suggests zoo-
notic transmission via consumption of undercooked
pork may also contribute to the burden of HEV in
Nepal. However, to date, isolation of HEV genotype 3
from humans associated with swine has not been re-
ported in Nepal.
Donors’ responses to drinking water source and
method of water treatment were solely based on their
preference and their practice of water collection and
treatment. Therefore, risk from other sources of water
consumed could have also contributed to seropositivity.
Based on our observation, lower HEV IgG sero-
prevalence was associated with individuals relying on an
underground water source. A potential explanation
could be less likelihood of faecal contamination of
underground water compared to other sources. With the
drinking water pipelines being adjacent to the sewer sys-
tem in the Kathmandu district, there is a chance that the
drinking water could be contaminated in the event of
sewer leakage. Underground water is usually sourced
from deep below the earth’s surface and collected dir-
ectly by manual hand pumps or water pumps and there-
fore there is a lower possibility of contamination.
HEV IgG prevalence in the blood donor population
studied was relatively high. This is in a similar range to
previous estimates in Nepal based on population studies[9, 12]. HEV IgG prevalence was highest in Bhaktapur
and lowest was in Chitwan, indicating HEV exposure
varies between the different regions of Nepal. Geography
and other factors, such as water supply systems, in these
districts are likely to contribute to these observed differ-
ences. HEV IgG prevalence increased with age, which is
in agreement with studies in other countries [41, 43],
and indicates cumulative exposure. However, this obser-
vation differs from previous studies in Nepal, which have
shown non-uniform increase with age [9, 12]. The vari-
ation is likely to be due to differences in cohort selection
between the studies.
Conclusions
HEV infection in Nepalese blood donors is comparable
to the general population. Past exposure to HEV was as-
sociated with multiple factors, including age, district of
blood collection and consumption of pork. In developing
countries like Nepal, where the main transmission route
is faecal oral, other modes of transmission including
zoonotic and transfusion may also occur. Detection of
recent HEV infection in the donor population demon-
strates the risk of transfusion-transmission in vulnerable
patients in Nepal. Unexpectedly, this study did not
provide evidence of a sizeable HEV outbreak after the
devastating earthquakes in 2015.
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